Completed NA INTERVENTIONAL 1-arm NCT06042400

Trial of Written Exposure for Metastatic Cancer Patients (EASE)

Pilot Trial of Written Exposure Intervention for Metastatic Cancer Patients: The EASE Study

Sponsor: University of Colorado, Boulder

Conditions Anxiety Fear of Cancer Progression Lymphoproliferative Disorders Metastatic Cancer Post-traumatic Stress Symptoms Solid Tumor Cancer

Interventions Written Exposure Therapy

Updated 4 times since 2023 Last updated: Dec 1, 2023 Started: Apr 18, 2022 Primary completion: Sep 21, 2023 Completion: Sep 21, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Anxiety and Fear of Cancer Progression, this trial is completed. The trial is conducted by University of Colorado, Boulder and has accumulated 4 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2024 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Oct 2023 — Jan 2024 [monthly]

Recruiting NA

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Colorado, Boulder
University of Colorado, Denver

Data source: University of Colorado, Boulder

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boulder, United States